OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001262104

Lite Strategy, Inc. (LITS)

Lite Strategy, Inc. (CIK 0001262104, ticker LITS, EIN 51-0407811) reported revenue of $0 for FY2025 (2024-07-01 to 2025-06-30) and net income of -$71.15 million (-$71,150,000) for FY2026 (2025-07-01 to 2026-06-30), as filed in its 10-K filed 2025-09-26 (accession 0001193125-25-220421) and its 10-K filed 2026-09-28 (accession 0001193125-26-405328).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends June 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001262104
TickersLITS (Nasdaq)
EIN51-0407811
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endJune 30
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_0x4yw3xeq27k6yxn63aj872wzk
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0FY20252024-07-01 to 2025-06-3010-K2025-09-260001193125-25-220421Revenues
Net income-$71,150,000FY20262025-07-01 to 2026-06-3010-K2026-09-280001193125-26-405328NetIncomeLoss
Total assets$42,692,000FY2026as of 2026-06-3010-K2026-09-280001193125-26-405328Assets
Total liabilities$1,069,000FY2026as of 2026-06-3010-K2026-09-280001193125-26-405328Liabilities
Stockholders' equity$41,623,000FY2026as of 2026-06-3010-K2026-09-280001193125-26-405328StockholdersEquity
Operating cash flow-$9,121,000FY20262025-07-01 to 2026-06-3010-K2026-09-280001193125-26-405328NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$2.06 per shareFY20262025-07-01 to 2026-06-3010-K2026-09-280001193125-26-405328EarningsPerShareDiluted
Shares outstanding30,407,268 sharesFY2026as of 2026-09-2210-K2026-09-280001193125-26-405328EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2017-2026, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20252024-07-01 to 2025-06-30$010-K2025-09-260001193125-25-220421
RevenueFY20242023-07-01 to 2024-06-30$65,297,00010-K2025-09-260001193125-25-220421
RevenueFY20232022-07-01 to 2023-06-30$48,816,00010-K2024-09-190000950170-24-108185
RevenueFY20222021-07-01 to 2022-06-30$40,697,00010-K2023-09-260000950170-23-049927
RevenueFY20212020-07-01 to 2021-06-30$34,796,00010-K2022-09-080000950170-22-018236
RevenueFY20202019-07-01 to 2020-06-30$27,756,00010-K2022-09-080000950170-22-018236
RevenueFY20192018-07-01 to 2019-06-30$4,915,00010-K/A2022-05-230000950170-22-010487
RevenueFY20182017-07-01 to 2018-06-30$1,622,00010-K2020-09-090001193125-20-242169
RevenueFY20172016-07-01 to 2017-06-30$23,249,00010-K2019-08-280001193125-19-232454
Net incomeFY20262025-07-01 to 2026-06-30-$71,150,00010-K2026-09-280001193125-26-405328
Net incomeFY20252024-07-01 to 2025-06-30-$15,945,00010-K2026-09-280001193125-26-405328
Net incomeFY20242023-07-01 to 2024-06-30$18,000,00010-K2026-09-280001193125-26-405328
Net incomeFY20232022-07-01 to 2023-06-30-$32,000,00010-K2025-09-260001193125-25-220421
Net incomeFY20222021-07-01 to 2022-06-30-$54,000,00010-K/A2023-10-270000950170-23-055978
Net incomeFY20212020-07-01 to 2021-06-30-$41,000,00010-K/A2023-10-270000950170-23-055978
Net incomeFY20202019-07-01 to 2020-06-30-$47,173,00010-K2022-09-080000950170-22-018236
Net incomeFY20192018-07-01 to 2019-06-30-$16,819,00010-K/A2022-05-230000950170-22-010487
Net incomeFY20182017-07-01 to 2018-06-30-$40,068,00010-K2020-09-090001193125-20-242169
Net incomeFY20172016-07-01 to 2017-06-30$2,670,00010-K2019-08-280001193125-19-232454
  • Revenue for FY2021 was restated: first reported as $25,535,000 (accession 0000950170-21-001655, filed 2021-09-02).
  • Revenue for FY2020 was restated: first reported as $28,913,000 (accession 0001193125-20-242169, filed 2020-09-09).
  • Net income for FY2024 was restated: first reported as $17,778,000 (accession 0000950170-24-108185, filed 2024-09-19).
  • Net income for FY2023 was restated: first reported as -$31,838,000 (accession 0000950170-23-049927, filed 2023-09-26).
  • Net income for FY2022 was restated: first reported as -$54,454,000 (accession 0000950170-22-018236, filed 2022-09-08).
  • Net income for FY2021 was restated: first reported as -$50,575,000 (accession 0000950170-21-001655, filed 2021-09-02).
  • Net income for FY2020 was restated: first reported as -$46,016,000 (accession 0001193125-20-242169, filed 2020-09-09).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-K2026-09-282026-06-300001193125-26-405328lits-20260630.htm
10-Q2026-05-132026-03-310001193125-26-220687lits-20260331.htm
10-Q2026-02-172025-12-310001193125-26-053215lits-20251231.htm
10-Q2025-11-142025-09-300001193125-25-283111lits-20250930.htm
10-K2025-09-262025-06-300001193125-25-220421lits-20250630.htm
10-Q2025-05-132025-03-310000950170-25-070276meip-20250331.htm
10-Q2025-02-122024-12-310000950170-25-018809meip-20241231.htm
10-Q2024-11-122024-09-300000950170-24-125328meip-20240930.htm
10-K2024-09-192024-06-300000950170-24-108185meip-20240630.htm
10-Q2024-05-092024-03-310000950170-24-056834meip-20240331.htm
10-Q2024-02-132023-12-310000950170-24-014640meip-20231231.htm
10-Q2023-11-092023-09-300000950170-23-061976meip-20230930.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001262104published by the sourcedata.sec.gov/submissions/CIK0001262104.json2026-10-21
Employer Identification Number (EIN) · US-EIN51-0407811published by the sourcedata.sec.gov/submissions/CIK0001262104.json2026-10-21

Former names

NameFromTo
MEI Pharma, Inc.2012-07-022025-09-10
MARSHALL EDWARDS INC2003-09-252012-06-06

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001262104.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001262104.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001262104" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001262104/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001262104/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1262104"}

On SEC EDGAR

About this data